Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marni C Wiseman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Leukemia & Lymphoma|June 26, 2019
Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survivalGanchimeg Ishdorj, Sara Beiggi, Zoann Nugent, et al.
Journal of the American Academy of Dermatology|July 25, 2024
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)Brett King, Maryanne M Senna, Natasha A Mesinkovska, et al.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
Journal of Cosmetic Dermatology|May 20, 2020
Nonprescription acne vulgaris treatments: Their role in our treatment armamentarium-An international panel discussionBrigitte Dréno, Elena Araviiskaia, Delphine Kerob, et al.
JAMA Dermatology|March 30, 2022
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With PsoriasisAstrid M van Huizen, Stef P Menting, Rolland Gyulai, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Leukemia & Lymphoma|June 26, 2019
Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survivalGanchimeg Ishdorj, Sara Beiggi, Zoann Nugent, et al.
Journal of the American Academy of Dermatology|July 25, 2024
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)Brett King, Maryanne M Senna, Natasha A Mesinkovska, et al.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
Journal of Cosmetic Dermatology|May 20, 2020
Nonprescription acne vulgaris treatments: Their role in our treatment armamentarium-An international panel discussionBrigitte Dréno, Elena Araviiskaia, Delphine Kerob, et al.
JAMA Dermatology|March 30, 2022
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With PsoriasisAstrid M van Huizen, Stef P Menting, Rolland Gyulai, et al.
Pageof 3